Skip to main content

HB 1461 — Maryland

Health Insurance - Coverage for Specialty Drugs - Rheumatologic Conditions

Introduced 2026 session House of Delegates

This page lists STATE bills only. Open States, our source for this data, tracks state legislatures -- it has no visibility into city councils, county commissions or school boards. We don't yet have a free, storable source for local measures; see the About page for why.

Summary

  • HB 1461 is a bill in the Maryland House of Delegates, 2026 session, introduced February 13, 2026.
  • Sponsored by Taveras, Lehman, and Williams.
  • Current status: introduced.
  • Most recent action (March 13, 2026): Hearing 3/13 at 1:30 p.m.
  • Subjects: Drugs, Health, Health - Insurance, Health Insurance, Health Maintenance Organizations, Medical Conditions.

Contact your legislator about this bill

Bill text & documents

Sponsors

Primary: Taveras, Lehman, Williams

History

  1. Introduced, completed
  2. Passed House of Delegates, in progress
  3. Passed Senate, not reached yet
  4. Sent to Governor, not reached yet
  5. Signed into law, not reached yet
  1. House of Delegates First Reading Health
  2. House of Delegates Hearing 3/13 at 1:00 p.m.
  3. House of Delegates Hearing canceled
  4. House of Delegates Hearing 3/13 at 3:00 p.m.
  5. House of Delegates Hearing canceled
  6. House of Delegates Hearing 3/13 at 1:30 p.m. Latest

Source: Open States. Last checked November 12, 2026. How we keep this accurate ›